Q4 2023 Holdings
Filed 2024-02-14 | 39 holdings | $177.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rayzebio Inc | COM | 75525N107 | $23.5M | 378,069 | 13.2% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $11.6M | 492,155 | 6.5% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $11.0M | 366,015 | 6.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $10.1M | 701,349 | 5.7% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $9.8M | 425,128 | 5.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.4M | 117,373 | 4.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $6.8M | 70,600 | 3.8% |
| Praxis Precision Medicines I(PRAX) | COM | 74006W207 | $6.7M | 299,636 | 3.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $6.7M | 115,500 | 3.8% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $6.4M | 3,589,333 | 3.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $6.1M | 281,500 | 3.5% |
| Tourmaline BIO Inc.(TRML) | COM | 89157D105 | $6.1M | 231,882 | 3.4% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $5.8M | 1,310,000 | 3.3% |
| Mersana Therapeutics Inc | COM | 59045L106 | $5.5M | 2,368,000 | 3.1% |
| Hillevax Inc | COM | 43157M102 | $5.2M | 324,600 | 2.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $5.0M | 119,489 | 2.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $4.6M | 160,000 | 2.6% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $4.6M | 76,100 | 2.6% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $4.3M | 77,000 | 2.4% |
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $3.7M | 1,849,402 | 2.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $3.6M | 555,260 | 2.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $3.1M | 87,500 | 1.8% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $2.8M | 69,400 | 1.5% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $2.7M | 132,000 | 1.5% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $2.0M | 147,836 | 1.1% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $1.9M | 232,249 | 1.1% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $1.8M | 525,100 | 1.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $1.7M | 123,876 | 1.0% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $1.5M | 74,500 | 0.8% |
| Leap Therapeutics Inc(CYPH) | COM NEW | 52187K200 | $1.5M | 354,166 | 0.8% |
| Cellectar Biosciences Inc(CLRBUSD) | COM NEW | 15117F807 | $1.3M | 477,500 | 0.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $914.2K | 29,500 | 0.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $913.0K | 2,400 | 0.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $377.7K | 19,000 | 0.2% |
| Springworks Therapeutics Inc | COM | 85205L107 | $365.0K | 10,000 | 0.2% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $303.6K | 38,138 | 0.2% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $122.8K | 8,867 | 0.1% |
| Anavex Life Sciences Corp(AVXL)Put | COM NEW | 032797300 | $22.5K | 1,000 | 0.0% |
| Nuvation BIO(NUVB/WS) | *W EXP 07/07/2027 | 67080N119 | $5.5K | 90,832 | 0.0% |